Cell-based intestinal absorption models combined with food and digestive matrixes to study toxicity and in vitro bioavailability of food bioactives and contaminants
Commonly used acronym: bioavailability
Scope of the method
- Human health
- Basic Research
- In vitro - Ex vivo
- Human derived cells / tissues / organs
Description
- bioavailability
- digestion
- intestine
- food
- bioactives
- toxins
- epithelial barrier function
- bioaccessibility
- bioavailability
- food
- effect of food matrix on availability of compounds
- cytotoxicity
- digestion
A set of protocols to combine the widely used Caco-2 cell line with digests from in vitro digestion models (small intestine, colon) to study toxicity, intestinal barrier integrity, bioavailability and, when combined with other cell models (immune, liver, endothelium), bioactivity of food related bioactives and contaminants.
- - Cell culture facilities;
- - Trans-epithelial electrical resistance measurements;
- - Fluorescence plate reader;
- - Advanced analytical techniques.
- History of use
- Published in peer reviewed journal
Pros, cons & Future potential
- - Includes relevant food and digestive matrices;
- - Barrier and transport assays combined.
- - Case-per-case optimization;
- - Toxicity.
References, associated documents and other information
Van Rymenant, E., Salden, B., Voorspoels, S., Jacobs, G., Noten, B., Pitart, J., Possemiers, S., Smagghe, G., Grootaert, C., Van Camp, J. A critical evaluation of in vitro hesperidin 2S bioavailability in a model combining luminal (microbial) digestion and Caco-2 cell absorption in comparison to a randomized controlled human trial. 2018. MOLECULAR NUTRITION & FOOD RESEARCH. 62(8).
Contact person
Charlotte GrootaertOrganisations
Ghent University (UGent)Food Technology, Safety and Health
Ghent University
092649392
Belgium
Flemish Region